Search Results - "Chichili, G.R."

138 Preclinical activity and safety of MGD006, a CD123xCD3 Bispecific DART® molecule for the treatment of hematological malignancies by Moore, P, Chichili, G.R, Huang, L, Li, H, Burke, S, Chen, F, He, L, Tang, Q, Jin, L, Gorlatov, S, Ciccarone, V, Koenig, S, Shannon, M, Alderson, R, Johnson, S, Bonvini, E

Get full text

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors by Bang, Y.J., Giaccone, G., Im, S.A., Oh, D.Y., Bauer, T.M., Nordstrom, J.L., Li, H., Chichili, G.R., Moore, P.A., Hong, S., Stewart, S.J., Baughman, J.E., Lechleider, R.J., Burris, H.A.

“…Margetuximab is an anti-HER2 antibody that binds with elevated affinity to both the lower and higher affinity forms of CD16A, an Fc-receptor important for…”
Get full text

Protective effects of tomato extract with elevated β-carotene levels on oxidative stress in ARPE-19 cells by Chichili, Gurunadh R., Nohr, Donatus, Frank, Jürgen, Flaccus, Andrea, Fraser, Paul D., Enfissi, Eugenia M. A., Biesalski, Hans K.

“…Epidemiological studies show that dietary products rich in carotenoids delay the progression of age-related macular degeneration. Experimental evidence from…”
Get full text